Dr. MacKinnon agrees about the importance of a personalized approach to multimodal preoperative cocktails and says this phase of care ultimately comes down to three things: A provider’s experience with different drugs, the time they’ve
spent reading the current research and talking to other providers about what they’ve done in the multimodal space, and their ability to tailor the approach to the patient’s health history.
Past and current opioid usage is obviously an important factor in creating an opioid-sparing analgesia regimen. “These individuals are enzymatically induced to burn through opioids much faster, but you can utilize other drugs to hit different
nerve receptors,” says Dr. MacKinnon. Opioid usage isn’t the only thing that can diminish the effectiveness of preoperative painkillers on patients — regular or weekend binge drinking and marijuana usage can do so as well.
The four most common drugs that Dr. MacKinnon uses for opioid-sparing analgesia are dexmedetomidine, a drug that prevents central sensitization or the development of chronic pain; ketamine, an NMDA antagonist; and magnesium and lidocaine, both
of which also prevent central sensitization.
Whether he uses all these medications, one of them or some in combination with small doses of opioids depends on the type of procedure being performed. For instance, he can start an IV of all four drugs, run it for the bulk of a two- or three-hour
surgery and turn off the drip a half-hour before the end of the case. In these cases, the patient wakes up with little discomfort. For faster procedures, this regimen usually isn’t necessary. “I might give just a small bolus of
one or two of the medications,” says Dr. MacKinnon. That’s the beauty of multimodal pain management — you tailor it the patient, the surgery and the situation.
• Regional anesthesia. The ability to target and block the specific location of a patient’s pain is a critical component of analgesia. Indeed, many anesthesia providers see regional anesthesia as the most important component
of pain control. “The biggest part of multimodal analgesia is regional anesthesia,” says Dr. MacKinnon. “If you can block a specific nerve, the concern of pain becomes a non-issue.”
Dr. Durick was an early adopter of nerve blocks and urges other providers to always consider this option for all patients — especially those with increased pain management needs. Whether it’s a fascial plane block like a PECS I and
II or TAP block, or an ultrasound-guided nerve block like an adductor canal or brachial plexus nerve block, Dr. Durick suggests addressing the possibility of administering a block — even there’s potential for it to be placed postoperatively
— with the patient before the surgery and get them to sign a consent. This way, he says, the consent is already in place should you need to perform a rescue block.
Regardless of whether your anesthesia providers employ single-shot or continuous nerve blocks with programmable pain pumps, Dr. Durick says the key to improved outcomes is ensuring patients are comfortable enough to start rehab and physical therapy
before they leave your facility and during the critical first few days at home. “Extended analgesia allows patients to move without pain soon after surgery, decreases scarring and clot formation, and improves post-op functionality,”
he explains.